These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 29665129
21. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation. Bartolome A, Boskovic S, Paunovic I, Bozic V, Cvejic D. APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533 [Abstract] [Full Text] [Related]
22. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer. Dong W, Li J, Zhang H, Huang Y, He L, Wang Z, Shan Z, Teng W. Int J Clin Exp Pathol; 2015 Apr; 8(6):7149-56. PubMed ID: 26261608 [Abstract] [Full Text] [Related]
23. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma. Šelemetjev S, Ðoric I, Paunovic I, Tatic S, Cvejic D. Am J Clin Pathol; 2016 Nov 01; 146(5):594-602. PubMed ID: 27806941 [Abstract] [Full Text] [Related]
29. FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes. Kessler BE, Sharma V, Zhou Q, Jing X, Pike LA, Kerege AA, Sams SB, Schweppe RE. Mol Cancer Res; 2016 Sep 27; 14(9):869-82. PubMed ID: 27259715 [Abstract] [Full Text] [Related]
30. Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma. Choi YW, Kim YH, Lee J, Soh EY, Park TJ, Kim JH. Hum Pathol; 2015 Oct 27; 46(10):1557-65. PubMed ID: 26297257 [Abstract] [Full Text] [Related]
31. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma]. Yue C, Zhao X, Tian C, Jin Y, Liu H. Zhonghua Bing Li Xue Za Zhi; 2015 Jul 27; 44(7):490-4. PubMed ID: 26705040 [Abstract] [Full Text] [Related]
34. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Behmoaram E, Bijian K, Jie S, Xu Y, Darnel A, Bismar TA, Alaoui-Jamali MA. Am J Pathol; 2008 Nov 27; 173(5):1540-50. PubMed ID: 18832579 [Abstract] [Full Text] [Related]
35. Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study. Kim SJ, Park JW, Yoon JS, Mok JO, Kim YJ, Park HK, Kim CH, Byun DW, Lee YJ, Jin SY, Suh KI, Yoo MH. J Korean Med Sci; 2004 Oct 27; 19(5):710-5. PubMed ID: 15483349 [Abstract] [Full Text] [Related]
36. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations. Meng XY, Zhang Q, Li Q, Lin S, Li J. J Int Med Res; 2014 Jun 27; 42(3):619-27. PubMed ID: 24670538 [Abstract] [Full Text] [Related]
37. Clinical significance of focal adhesion kinase in resectable pancreatic cancer. Furuyama K, Doi R, Mori T, Toyoda E, Ito D, Kami K, Koizumi M, Kida A, Kawaguchi Y, Fujimoto K. World J Surg; 2006 Feb 27; 30(2):219-26. PubMed ID: 16425085 [Abstract] [Full Text] [Related]
38. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma. Luo D, Chen H, Li X, Lu P, Long M, Peng X, Lin S, Tan L, Zhu Y, Ouyang N, Li H. Int J Oncol; 2017 Oct 27; 51(4):1209-1218. PubMed ID: 28848996 [Abstract] [Full Text] [Related]
39. Focal Adhesion Kinase (FAK) Overexpression and Phosphorylation in Oral Squamous Cell Carcinoma and their Clinicopathological Significance. Kato A, Kato K, Miyazawa H, Kobayashi H, Noguchi N, Kawashiri S. Pathol Oncol Res; 2020 Jul 27; 26(3):1659-1667. PubMed ID: 31522363 [Abstract] [Full Text] [Related]
40. Expression of focal adhesion kinase (p125 FAK) and proline-rich tyrosine kinase 2 (PYK2/CAKb) in cerebral metastases, correlation with VEGF-R-, ecNOS III-labelling and morphometric data. Ludwig HC, Akhavan-Shigari R, Rausch S, Schallock K, Quentin C, Bockermann V, Kolenda H. Anticancer Res; 2000 Jul 27; 20(3A):1419-24. PubMed ID: 10928051 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]